ARK Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8M | Sell |
|
|||||
|
2025
Q1 | $57.5M | Sell |
|
|||||
|
2024
Q4 | $56.5M | Sell |
|
|||||
|
2024
Q3 | $59.4M | Buy |
|
|||||
|
2024
Q2 | $41.3M | Buy |
|
|||||
|
2024
Q1 | $33.9M | Sell |
|
|||||
|
2023
Q4 | $62.8M | Buy |
|
|||||
|
2023
Q3 | $62.7M | Buy |
|
|||||
|
2023
Q2 | $70.1M | Buy |
|
|||||
|
2023
Q1 | $81.3M | Buy |
|
|||||
|
2022
Q4 | $70.3M | Sell |
|
|||||
|
2022
Q3 | $66.5M | Buy |
|
|||||
|
2022
Q2 | $68.6M | Buy |
|
|||||
|
2022
Q1 | $107M | Buy |
|
|||||
|
2021
Q4 | $160M | Buy |
|
|||||
|
2021
Q3 | $165M | Buy |
|
|||||
|
2021
Q2 | $178M | Buy |
|
|||||
|
2021
Q1 | $140M | Buy |
|
|||||
|
2020
Q4 | $91.4M | Buy |
|
|||||
|
2020
Q3 | $43M | Buy |
|
|||||
|
2020
Q2 | $15M | Buy |
|